SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-15-000159
Filing Date
2015-02-20
Accepted
2015-02-20 17:02:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 20, 2015 navidea13g-022015.htm SC 13G 177327
  Complete submission text file 0001013594-15-000159.txt   178968
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43603 | Film No.: 15636542
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 212-581-0500
Platinum Partners Value Arbitrage Fund, LP (Filed by) CIK: 0001299265 (see all company filings)

IRS No.: 141861954 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G